The COST Action BM1304, “Applications of MR imaging and spectroscopy techniques in neuromuscular disease: collaboration on outcome measures and pattern recognition for diagnostics and therapy development”, was approved by the COST Committee of Senior Officials on Wednesday 15 May, 2013.
- Improve diagnosis and understanding of muscle pathology: online atlas
- Develop multicentric imaging outcome measures: SOPs
- Explore new contrasts, targets and imaging techniques for NMD: clinical testing
- Explore strategies for muscle imaging texture analysis: validated algorithms
Volker Straub, Institute of Genetic Medicine, Newcastle University, UK